YY1 is a well-known oncogenic transcription factor that promotes the initiation, progression, or drug resistance of various cancers, including prostate cancer, cervical cancer, bladder cancer, gastric cancer, and colorectal cancer, through multiple mechanisms [51–55]. This evidence concerns the gene YY1 and urinary bladder cancer.